Subscribe
sanofi
Monticello / Shutterstock
6 June 2023FeaturesBig PharmaMuireann Bolger

Sanofi v Amgen antibody case lands front of queue at UPC

The  Unified Patent Court (UPC) may be less than a week old but it is already set to be the latest stage for the long-running dispute between Sanofi and Amgen concerning antibody patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.

More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.

More features

Dexcom suffers second patent revocation at hands of UPC
Sanofi signs global rights deal to develop rare cancer therapy
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
UPC delivers first 'imminent infringement' decision in biosimilar dispute
AstraZeneca unit draws line under Samsung dispute
Does the UPC offer a fresh take on patent validity?
UPC: First decisions on merits are ‘testimony to judges’ tight case management’
UK firm prevails in ‘exceptionally slow’ UPC test case